Data / Form D filings / IMBED BIOSCIENCES, INC
IMBED BIOSCIENCES, INC: Form D filings
IMBED BIOSCIENCES, INC, a biotechnology company in Middleton, WI, filed 10 Form D notices with the SEC between 2014 and 2023. The latest, on December 29, 2023, reports $3.5 million sold of a $3.6 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2241 Pinehurst Drive, Middleton, WI, 53562
- Phone
- (888) 472-9898
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1606055
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 29, 2023 | New notice | $3,600,000 | $3,500,000 | $100,000 | 1 | Dec 14, 2023 | sec.gov |
| May 31, 2023 | New notice | $6,000,000 | $2,500,000 | $3,500,000 | 2 | May 17, 2023 | sec.gov |
| Nov 24, 2021 | New notice | $14,235,872 | $7,892,399 | $6,343,473 | 37 | Nov 11, 2021 | sec.gov |
| Jun 18, 2020 | New notice | $1,507,600 | $1,494,000 | $13,600 | 18 | Jun 3, 2020 | sec.gov |
| Oct 7, 2019 | Amendment | $4,148,992 | $4,028,965 | $120,027 | 47 | Oct 12, 2018 | sec.gov |
| Oct 29, 2018 | New notice | $3,500,000 | $1,055,120 | $2,444,880 | 14 | Oct 12, 2018 | sec.gov |
| Dec 28, 2017 | New notice | $1,656,667 | $1,571,948 | $84,719 | 11 | Dec 14, 2017 | sec.gov |
| Aug 18, 2016 | New notice | $750,000 | $600,000 | $150,000 | 3 | Aug 5, 2016 | sec.gov |
| Sep 4, 2014 | Amendment | $1,050,000 | $683,275 | $366,725 | 8 | Apr 11, 2014 | sec.gov |
| Apr 24, 2014 | New notice | $250,000 | $180,000 | $70,000 | 7 | Apr 11, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Philip Foster | Director | |
| Ankit Agarwal | Executive Officer, Director | |
| Walter Dewey | Director | |
| David Guinther | Director | |
| Jonathan Black | Director | |
| Elizabeth Taylor | Executive Officer |
Every Form D from the week of Dec 25, 2023 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what IMBED BIOSCIENCES, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.